Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Class A ordinary shares, par value US$0.0001 per share
-
Shares outstanding
-
445M
-
Number of holders
-
411
-
Total 13F shares, excl. options
-
320M
-
Shares change
-
+10.8M
-
Total reported value, excl. options
-
$8.18B
-
Value change
-
+$265M
-
Put/Call ratio
-
0.23
-
Number of buys
-
212
-
Number of sells
-
-185
-
Price
-
$25.51
Significant Holders of Royalty Pharma plc - Class A ordinary shares, par value US$0.0001 per share (RPRX) as of Q4 2024
472 filings reported holding RPRX - Royalty Pharma plc - Class A ordinary shares, par value US$0.0001 per share as of Q4 2024.
Royalty Pharma plc - Class A ordinary shares, par value US$0.0001 per share (RPRX) has 411 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 320M shares
of 445M outstanding shares and own 71.99% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (39.5M shares), VANGUARD GROUP INC (37.4M shares), FMR LLC (26.4M shares), BlackRock, Inc. (25.4M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (17M shares), BAILLIE GIFFORD & CO (14.1M shares), VIKING GLOBAL INVESTORS LP (12.2M shares), Swedbank AB (12.2M shares), STATE STREET CORP (9.76M shares), and GEODE CAPITAL MANAGEMENT, LLC (7.31M shares).
This table shows the top 411 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.